T Cell News and Research

Latest T Cell News and Research

Discovery of a receptor that appears to function as one "lock" that HSV opens to allow it to enter human cells

It's one of the most common viruses in America, and one that causes the most guilt and shame. It can get inside almost any kind of human cell, reproduce in vast numbers, and linger for years in the body, causing everything from recurrent genital blisters to sores around the mouth. Its complications can kill, and it may increase susceptibility to many nerve and brain disorders.

24 Jul 2005

Role of IL-24 in regulating the immune system

Researchers at Introgen Therapeutics and their collaborators at The University of Texas M. D. Anderson Cancer Center have published new findings on the role of IL-24 in regulating the immune system in the current online issue of the Journal of Leukocyte Biology.

21 Jul 2005

Crucial molecular link between a hepatitis B virus (HBV) and hepatocellular carcinoma (HCC)

Researchers at The University of Texas M. D. Anderson Cancer Center have uncovered a crucial molecular link between a viral infection and development of a common and fatal form of liver cancer. In the process, they have identified a possible way to treat this disease as well as a number of other cancers.

21 Jul 2005

Does the heart contain stem cells that are self-renewing?

If you've ever used a loofah in the shower, you've stirred up some stem cells. As the outer layer of skin sloughs off, stem cells in the dermis rush to repair and replace those buffed away.

21 Jul 2005

Hearing protein TRPA1 also involved with pain perception

The same protein that “translates” sound into nerve signals to the brain and enables individuals to hear is also required for pain perception, researchers from Northwestern University Feinberg School of Medicine have found.

21 Jul 2005

Biological breakthrough that could offer new hope in the fight against liver cancer

Professor John Mayer and Dr Simon Dawson, in collaboration with colleagues at Japan's Kyoto University, have discovered the function of a new liver oncoprotein - or cancer causing protein - which could be the first step to finding effective new treatments for the deadly illness.

21 Jul 2005

Sanofi pasteur gear up for influenza pandemic with new plant

Work has officially begun on the construction of a new sanofi pasteur manufacturing facility that will expand the ability of the United States to produce influenza vaccine for both routine influenza immunization and in case of a global influenza pandemic.

21 Jul 2005

Imiquimod and fluorouracil emerge as effective weapons for treating superficial basal cell carcinomas

Basal cell carcinoma, a type of skin cancer, affects millions of people worldwide. While traditional treatment has been surgery and radiation, topical treatments in combination with surgery are showing more promise for patients with basal cell carcinoma.

21 Jul 2005

New program will help fill a drug-discovery void as pharmaceutical companies have largely abandoned natural products research

The natural world has been medicine's most effective arsenal, providing life-saving antibiotics and our most potent anti-cancer drugs.

20 Jul 2005

Protein found in fat cells is a newly discovered cause of insulin resistance

A study led by researchers at Beth Israel Deaconess Medical Center (BIDMC) has shown that a protein found in fat cells is a newly discovered cause of insulin resistance, establishing a previously unidentified molecular link between obesity and type 2 diabetes and offering a potential new target for the development of drugs to treat diabetes.

20 Jul 2005

Australian stem cell discovery hailed as a major medical and scientific development

Monash Institute of Medical Research (MIMR) senior scientist Dr Caroline Gargett's discovery of adult stem cells in the uterus that can be grown into bone, muscle, fat and cartilage, has been hailed as a major medical and scientific development by international reproduction experts.

20 Jul 2005

Major stem cell discovery

Research published in Nature tomorrow (21 July) will outline for the first time the stem cell origin of the structure of the neck and shoulders in vertebrates.

20 Jul 2005

University of Florida researcher finds way to explore role of microRNAs in specific tissue

University of Florida researchers have learned how to selectively shut down a flyweight-sized genetic molecule that packs a heavyweight punch, a discovery that may help doctors better understand cancer, birth defects and other health problems.

20 Jul 2005

SIRT1 gene suppresses longevity

Researchers have determined that a gene present in mouse cells limits the number of times that a cell can divide. The gene is involved in a process, called senescence, which is thought to ensure that aging cells do not pass on harmful mutations.

20 Jul 2005

Insulin keeps fat in the liver under control

Insulin, a hormone long recognized as a generator of fat, also keeps fat in the liver under control, according to a new study in the July issue of Cell Metabolism.

19 Jul 2005

Pineapple stems that show anti-tumour activity

Scientists at the Queensland Institute of Medical Research (QIMR) have discovered two molecules from pineapple stems that show anti-tumour activity in laboratory studies. One molecule called CCS blocks a protein called Ras, which is defective in approximately 30% of all cancers. The other molecule called CCZ, stimulates the body's own immune system to target and kill cancer cells.

19 Jul 2005

Removing warts without scarring

If burning and freezing warts hasn't worked, ask your dermatologist about getting a shot.

19 Jul 2005

Chronic Obstructive Pulmonary Disease (COPD) rates in women skyrocket

The death rate for one of the most lethal diseases in North America has skyrocketed for women in the last 20 years, and a team of researchers from the University of British Columbia and the B.C. Centre of Excellence for Women's Health wants to find out why.

19 Jul 2005

Results demonstrate the safety and tolerability of ABthrax treatment for Anthrax infection

Human Genome Sciences has announced that results published in the current issue of Clinical Infectious Diseases demonstrate that the first investigational agent against anthrax infection to be evaluated in a clinical study since the 2001 anthrax attacks in the United States, is safe, well tolerated and achieves the blood levels predicted by relevant animal models as necessary to afford significant protection from the lethal effects of the anthrax toxin

19 Jul 2005